Ignite Creation Date:
2024-05-05 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00428038
Status:
COMPLETED
Last Update Posted:
2012-03-30
First Post:
2007-01-25
Brief Title:
Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease
Sponsor:
Indiana University
Organization:
Indiana University
Study Overview
Official Title:
Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate how easily gas can be taken up by the lung We are comparing infants born premature 32 weeks gestation to infants born full term 37 weeks We hope to evaluate the differences between the two groups in order to learn more about premature lung growth and development
Detailed Description:
We hypothesize that infants who were born prematurely but are clinically without chronic respiratory disease have a lower lung diffusion capacity than healthy infants born at full term when evaluated at comparable post-conception ages In addition prematurely born infants that develop chronic lung disease have an even lower diffusion capacity than healthy premature infants and full term infants A lower diffusion capacity when normalized to lung volume would be consistent with decreased alveolarization and alveolar surface area in the infants born prematurely We will study the age range of 1 to 24 month as this represents the period of rapid lung growth
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None